Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status
IntroductionImplementation of health technology assessment (HTA) is still in an early stage with some heterogeneity in the Middle East and North Africa (MENA). Our objective was to assess the current and future status of HTA implementation in the MENA region by focusing on regional commonalities.Met...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2020-02-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00015/full |
| _version_ | 1818063294775164928 |
|---|---|
| author | Ahmad Fasseeh Ahmad Fasseeh Rita Karam Mouna Jameleddine Mohsen George Finn Børlum Kristensen Abeer A. Al-Rabayah Abdulaziz H. Alsaggabi Maha El Rabbat Maha El Rabbat Maryam S. Alowayesh Julia Chamova Adham Ismail Sherif Abaza Zoltán Kaló Zoltán Kaló |
| author_facet | Ahmad Fasseeh Ahmad Fasseeh Rita Karam Mouna Jameleddine Mohsen George Finn Børlum Kristensen Abeer A. Al-Rabayah Abdulaziz H. Alsaggabi Maha El Rabbat Maha El Rabbat Maryam S. Alowayesh Julia Chamova Adham Ismail Sherif Abaza Zoltán Kaló Zoltán Kaló |
| author_sort | Ahmad Fasseeh |
| collection | DOAJ |
| description | IntroductionImplementation of health technology assessment (HTA) is still in an early stage with some heterogeneity in the Middle East and North Africa (MENA). Our objective was to assess the current and future status of HTA implementation in the MENA region by focusing on regional commonalities.MethodsPreparatory discussions for the first ISPOR conference in the MENA region indicated some potentially generalizable trends of HTA roadmaps. To widen the perspective, a policy survey was conducted among conference participants by applying an HTA implementation scorecard. Discussion group members helped to validate key conclusions during and after the conference.ResultsHealth policy experts in MENA countries would like to facilitate HTA implementation and expect significant changes with some generalizable directions in 10 years compared to the current status according. HTA capacity building has to be strengthened by more graduate and postgraduate programs. Increased public budget and enhanced institutionalization are necessary success factors of HTA implementation. The scope of HTA has to be extended from pharmaceuticals to non-pharmaceutical technologies and to revision of previous policy decisions. Although cost-effectiveness with explicit threshold remains the most preferred HTA criterion, several other criteria have to be considered, maybe even by applying an explicit MCDA framework. The role of local evidence and data has to be strengthened in MENA countries, which translates to the extended use of local patient registries and payers' databases. Duplication of efforts can be reduced if international collaboration is integrated into national HTA implementation.DiscussionOur results should be viewed as an initial step in a multi-stakeholder dialogue on HTA implementation. Each MENA country should develop its context-specific HTA roadmap, as such roadmaps are not transferable without taking into account country size, economic status, public health priorities and adopted systems of health care financing. |
| first_indexed | 2024-12-10T14:17:49Z |
| format | Article |
| id | doaj.art-5e60a383b2fd43ad8992538755ec03b0 |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-12-10T14:17:49Z |
| publishDate | 2020-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-5e60a383b2fd43ad8992538755ec03b02022-12-22T01:45:18ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-02-011110.3389/fphar.2020.00015502971Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred StatusAhmad Fasseeh0Ahmad Fasseeh1Rita Karam2Mouna Jameleddine3Mohsen George4Finn Børlum Kristensen5Abeer A. Al-Rabayah6Abdulaziz H. Alsaggabi7Maha El Rabbat8Maha El Rabbat9Maryam S. Alowayesh10Julia Chamova11Adham Ismail12Sherif Abaza13Zoltán Kaló14Zoltán Kaló15Doctoral School of Sociology, Faculty of Social Sciences, Eötvös Loránd University Budapest, Budapest, HungarySyreon Middle East, Alexandria, EgyptFaculty of Sciences and Medical Sciences, Lebanese University, Hadath, LebanonHealth Technology Assessment Department, National Authority for Assessment & Accreditation in Healthcare (INEAS), Tunis, TunisiaUniversal Health Insurance Authority, Cairo, EgyptFaculty of Health Sciences, Department of Public Health, University of Southern Denmark, Odense, DenmarkDepartment of Pharmacy, Center for Drug Policy & Technology Assessment (CDPTA), King Hussein Cancer Center, Amman, JordanKing Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyad, Saudi ArabiaFaculty of Medicine, Cairo University, Cairo, Egypt0Middle East and North Africa Health Policy Forum, Cairo, Egypt1Department of Pharmacy Practice, Faculty of Pharmacy, Kuwait University, Jabriyah, Kuwait2Global Networks, ISPOR, Lawrenceville, NJ, USA3Regional Office for the Eastern Mediterranean, World Health Organization, Cairo, EgyptSyreon Middle East, Alexandria, Egypt4Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary5Syreon Research Institute, Budapest, HungaryIntroductionImplementation of health technology assessment (HTA) is still in an early stage with some heterogeneity in the Middle East and North Africa (MENA). Our objective was to assess the current and future status of HTA implementation in the MENA region by focusing on regional commonalities.MethodsPreparatory discussions for the first ISPOR conference in the MENA region indicated some potentially generalizable trends of HTA roadmaps. To widen the perspective, a policy survey was conducted among conference participants by applying an HTA implementation scorecard. Discussion group members helped to validate key conclusions during and after the conference.ResultsHealth policy experts in MENA countries would like to facilitate HTA implementation and expect significant changes with some generalizable directions in 10 years compared to the current status according. HTA capacity building has to be strengthened by more graduate and postgraduate programs. Increased public budget and enhanced institutionalization are necessary success factors of HTA implementation. The scope of HTA has to be extended from pharmaceuticals to non-pharmaceutical technologies and to revision of previous policy decisions. Although cost-effectiveness with explicit threshold remains the most preferred HTA criterion, several other criteria have to be considered, maybe even by applying an explicit MCDA framework. The role of local evidence and data has to be strengthened in MENA countries, which translates to the extended use of local patient registries and payers' databases. Duplication of efforts can be reduced if international collaboration is integrated into national HTA implementation.DiscussionOur results should be viewed as an initial step in a multi-stakeholder dialogue on HTA implementation. Each MENA country should develop its context-specific HTA roadmap, as such roadmaps are not transferable without taking into account country size, economic status, public health priorities and adopted systems of health care financing.https://www.frontiersin.org/article/10.3389/fphar.2020.00015/fullhealth technology assessmenteconomic evaluationevidence-based health policyMiddle East and North AfricaHTA implementation |
| spellingShingle | Ahmad Fasseeh Ahmad Fasseeh Rita Karam Mouna Jameleddine Mohsen George Finn Børlum Kristensen Abeer A. Al-Rabayah Abdulaziz H. Alsaggabi Maha El Rabbat Maha El Rabbat Maryam S. Alowayesh Julia Chamova Adham Ismail Sherif Abaza Zoltán Kaló Zoltán Kaló Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status Frontiers in Pharmacology health technology assessment economic evaluation evidence-based health policy Middle East and North Africa HTA implementation |
| title | Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status |
| title_full | Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status |
| title_fullStr | Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status |
| title_full_unstemmed | Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status |
| title_short | Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status |
| title_sort | implementation of health technology assessment in the middle east and north africa comparison between the current and preferred status |
| topic | health technology assessment economic evaluation evidence-based health policy Middle East and North Africa HTA implementation |
| url | https://www.frontiersin.org/article/10.3389/fphar.2020.00015/full |
| work_keys_str_mv | AT ahmadfasseeh implementationofhealthtechnologyassessmentinthemiddleeastandnorthafricacomparisonbetweenthecurrentandpreferredstatus AT ahmadfasseeh implementationofhealthtechnologyassessmentinthemiddleeastandnorthafricacomparisonbetweenthecurrentandpreferredstatus AT ritakaram implementationofhealthtechnologyassessmentinthemiddleeastandnorthafricacomparisonbetweenthecurrentandpreferredstatus AT mounajameleddine implementationofhealthtechnologyassessmentinthemiddleeastandnorthafricacomparisonbetweenthecurrentandpreferredstatus AT mohsengeorge implementationofhealthtechnologyassessmentinthemiddleeastandnorthafricacomparisonbetweenthecurrentandpreferredstatus AT finnbørlumkristensen implementationofhealthtechnologyassessmentinthemiddleeastandnorthafricacomparisonbetweenthecurrentandpreferredstatus AT abeeraalrabayah implementationofhealthtechnologyassessmentinthemiddleeastandnorthafricacomparisonbetweenthecurrentandpreferredstatus AT abdulazizhalsaggabi implementationofhealthtechnologyassessmentinthemiddleeastandnorthafricacomparisonbetweenthecurrentandpreferredstatus AT mahaelrabbat implementationofhealthtechnologyassessmentinthemiddleeastandnorthafricacomparisonbetweenthecurrentandpreferredstatus AT mahaelrabbat implementationofhealthtechnologyassessmentinthemiddleeastandnorthafricacomparisonbetweenthecurrentandpreferredstatus AT maryamsalowayesh implementationofhealthtechnologyassessmentinthemiddleeastandnorthafricacomparisonbetweenthecurrentandpreferredstatus AT juliachamova implementationofhealthtechnologyassessmentinthemiddleeastandnorthafricacomparisonbetweenthecurrentandpreferredstatus AT adhamismail implementationofhealthtechnologyassessmentinthemiddleeastandnorthafricacomparisonbetweenthecurrentandpreferredstatus AT sherifabaza implementationofhealthtechnologyassessmentinthemiddleeastandnorthafricacomparisonbetweenthecurrentandpreferredstatus AT zoltankalo implementationofhealthtechnologyassessmentinthemiddleeastandnorthafricacomparisonbetweenthecurrentandpreferredstatus AT zoltankalo implementationofhealthtechnologyassessmentinthemiddleeastandnorthafricacomparisonbetweenthecurrentandpreferredstatus |